Credit: Tonix Pharmaceuticals. Tonmya is a once-daily sublingual tablet of cyclobenzaprine HCI taken at bedtime for the treatment of fibromyalgia. Clinical trials have demonstrated that Tonmya reduces ...

Many people with fibromyalgia describe the chronic condition as a "bad case of the flu that never goes away," because they have widespread pain, wake up with stiff muscles and experience brain fog, ...

Fibromyalgia is a condition that can cause various symptoms involving pain and fatigue. A rheumatologist may treat this condition alongside a full medical team. Members of the treatment team may ...

Tonmya is expected to be available in the fourth quarter of 2025. The Food and Drug Administration (FDA) has approved Tonmya ™ (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of ...

New research has found that cognitive behavioral therapy may help people with fibromyalgia. The researchers were able to identify differences between fMRI scans between participants as well as a ...

Patients suffering from a condition characterized by pain and fatigue could find relief in the form of oral THC treatment, according to newly published research. The study, published in the German ...

Tonix Pharmaceuticals (TNXP) was able to have its New Drug Application of TNX-102 SL for the treatment of patients with Fibromyalgia accepted by the FDA. Not only was this regulatory application ...